Generic, Branded Generic and Proprietary Medicinal Products — Group 9 [3343311]

A Contract Award Notice
by BUSINESS SERVICES ORGANISATION, PROCUREMENT & LOGISTICS SERVICE

Source
OJEU
Type
Contract (Supply)
Duration
5 year (est.)
Value
£2M
Sector
HEALTH
Published
29 Jun 2022
Delivery
To 14 Dec 2030 (est.)
Deadline
n/a

Concepts

Location

Belfast

Geochart for 2 buyers and 24 suppliers

2 buyers

24 suppliers

Description

Generic, Branded Generic and Proprietary Medicinal Products — Group 9 [3343311]

Total Quantity or Scope

Generic, Branded Generic and Proprietary Medicinal Products — Group 9 [3343311] is established under the Medicinal Products Dynamic Purchasing System [131864]. The contract is awarded on behalf of the following contract participants: (i) Belfast Health and Social Care Trust (BHSCT); (ii) South Eastern Health and Social Care Trust (SEHSCT); (iii) Northern Health and Social Care Trust (NHSCT); (iv) Southern Health and Social Care Trust (SHSCT); (v) Western Health and Social Care Trust (WHSCT); (vi) Northern Ireland Ambulance Service (NIAS); (vii) Northern Ireland Blood Transfusion Service (NIBTS); (viii) Business Services Organisation (BSO); (ix) Public Health Agency (PHA); (x) Department of Health, Northern Ireland (DoH(NI)); (xi) Health and Social Care Board (HSCB).

Award Detail

1 Abbvie (Maidenhead)
  • Num offers: 32
  • Value: £50,933
2 Bayer (Reading)
  • Num offers: 32
  • Value: £135,280
3 Chiesi (Manchester)
  • Num offers: 32
  • Value: £57,251
  • Contractor is an SME.
4 DR Reddys Laboratories (Beverley)
  • Num offers: 32
  • Value: £81,154
  • Contractor is an SME.
5 Flynn Pharma (Stevenage)
  • Num offers: 32
  • Value: £24,845
  • Contractor is an SME.
6 Focus Pharmaceuticals (London)
  • Num offers: 32
  • Value: £4,560
  • Contractor is an SME.
7 Fresenius Kabi (Runcorn)
  • Num offers: 32
  • Value: £14,391
8 Glaxosmithkline (Brentford)
  • Num offers: 32
  • Value: £117,173
9 Martindale Pharma (Romford)
  • Num offers: 32
  • Value: £91,708
10 Medac Pharma (Stirling)
  • Num offers: 32
  • Value: £146,234
  • Contractor is an SME.
11 Mercury Pharmaceuticals (London)
  • Num offers: 32
  • Value: £235,281
  • Contractor is an SME.
12 Morningside Healthcare (Loughborough)
  • Num offers: 32
  • Value: £39,221
  • Contractor is an SME.
13 Napp Pharmaceuticals (Cambridge)
  • Num offers: 32
  • Value: £18,850
  • Contractor is an SME.
14 Neuraxpharm (Farnborough)
  • Num offers: 32
  • Value: £73,130
  • Contractor is an SME.
15 Ranbaxy (Hayes)
  • Num offers: 32
  • Value: £104,029
  • Contractor is an SME.
16 Ridge Pharma (Reading)
  • Num offers: 32
  • Value: £15,421
  • Contractor is an SME.
17 Rosemont Pharmaceuticals (Leeds)
  • Num offers: 32
  • Value: £9,632
18 Sandoz (Camberley)
  • Num offers: 32
  • Value: £16,360
19 Synchrony Pharma (Old Hatfield)
  • Num offers: 32
  • Value: £16,932
  • Contractor is an SME.
20 Takeda (London)
  • Num offers: 32
  • Value: £284,665
21 Teva (Castleford)
  • Num offers: 32
  • Value: £167,079
22 Thornton & Ross (Huddersfield)
  • Num offers: 32
  • Value: £43,427
23 Viatris Healthcare (Potters Bar)
  • Num offers: 32
  • Value: £288,307
24 Zentiva (London)
  • Num offers: 32
  • Value: £98,310

Award Criteria

Compliance with Contract Scope and Specification _
Supply and Delivery of Product: Same Working Day Delivery 5.0
Supply and Delivery of Product: Wholesale Distribution 5.0
Continuity of Supply: Minimum Committed Stockholding 8.0
Governance, Quality Control and Risk: Pharmaceutical Quality Assessment (PQA) Section 1 _
Governance, Quality Control and Risk: Pharmaceutical Quality Assessment (PQA) Section 2 – Section 6 (inclusive) 40.0
PRICE 42.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price and quality.

Other Information

The estimated total value of contract (excluding VAT) is GBP 2 000 000 to GBP 14 000 000. This estimated total value figure takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts document and provides for potential growth of up to 50% over the course of the contract. The total value of contract (detailed in section V.2.4)) awarded to each of the contractors indicated in this notice is based on an initial contract period of 24 months. It is important to note that there is available provision to extend this initial contract period in accordance with Section 2 of the SS17bc Commercial Conditions of Contract for Supplies Contracts document.

Reference

Domains